Lin G, Shieh C T, Ho H C, Chouhwang J Y, Lin W Y, Lu C P
Department of Chemistry, Institute of Biochemistry, National Chung-Hsing University, Taichung, Taiwan.
Biochemistry. 1999 Aug 3;38(31):9971-81. doi: 10.1021/bi982775e.
Alkyl-N-phenyl carbamates (2-8) (see Figure 1), alkyl-N-phenyl thiocarbamates (9-15), 2,2'-biphenyl-2-ol-2'-N-substituted carbamates (16-23), and 2, 2'-biphenyl-2-N-octadecylcarbamate-2'-N-substituted carbamates (24-31) are prepared and evaluated for their inhibition effects on porcine pancreatic cholesterol esterase and Pseudomona species lipase. All inhibitors are characterized as transient or pseudo substrate inhibitors for both enzymes. Both enzymes are not protected from inhibition and further inactivated by carbamates 2-8 and thiocarbamates 9-15 in the presence of trifluoroacetophenone. Therefore, carbamates 2-8 and thiocarbamates 9-15 are exceptions for active site binding inhibitors and are probably the second alkyl-chain binding-site-directed inhibitors for both enzymes. The inhibition data for carbamates 2-8 and thiocarbamates 9-15 are correlated with the steric constant, E(s), and the hydrophobicity constant, pi; however, the inhibition data are not correlated with the Taft substituent constant, sigma. A comparison of the inhibition data for carbamates 2-8 and thiocarbamates 9-15 toward both enzymes indicates that thiocarbamates 9-15 are more potent inhibitors than carbamates 2-8. A comparison of the inhibition data for cholesterol esterase and Pseudomona species lipase by carbamates 2-8 or thiocarbamates 9-15 indicates that cholesterol esterase is more sensitive to the E(s) and pi values than Pseudomona species lipase. The negative slope values for the logarithms of inhibition data for Pseudomona species lipase by carbamates 2-8 and thiocarbamates 9-15 versus E(s) and pi indicate that the second alkyl-chain-binding site of Pseudomona species lipase is huge, hydrophilic, compared to that of cholesterol esterase, and prefers to interact with a bulky, hydrophilic inhibitor rather than a small, hydrophobic one. On the contrary, the second alkyl-chain-binding site of cholesterol esterase prefers to bind to a small, hydrophobic inhibitor. Both enzymes are protected from inhibition by carbamates 16-23 in the presence of trifluoroacetophenone. Therefore, carbamates 16-23 are characterized as the alkyl chain binding site, esteratic site oxyanion active site directed pseudo substrate inhibitors for both enzymes. Both enzyme inhibition data for carbamates 16-22 are well-correlated with sigma alone. The negative rho values for these correlations indicate that the serine residue of both enzymes and carbamates 16-22 forms the tetrahedral species with more positive charges than inhibitors and the enzymes and follow the formation of the carbamyl enzymes with more positive charges than the tetrahedral species. Carbamates 24-31 are also exceptions for active site binding inhibitors and probably the second alkyl chain binding site-directed inhibitors for both enzymes. However, the enzyme inhibition constants for carbamates 24-31 are correlated with values of sigma, E(s), and pi. The negative rho values for these correlations indicate that both enzymes and carbamates 24-31 form the tetrahedral species with more positive charges than inhibitors and the enzymes and follow the formation of the carbamyl enzymes with more positive charges than those tetrahedral species. Therefore, carbamates 24-31 may bind to both the active sites and the second alkyl chain binding site and follow the evacuation of the active sites. A comparison of the rho values for cholesterol esterase and Pseudomona species lipase by carbamates 24-31 indicates that cholesterol esterase is much more sensitive to the sigma values than Pseudomona species lipase. The negative sensitivity values, delta, for the cholesterol esterase inhibitions by carbamates 24-31 indicate that the enzyme prefers to bind to a bulky carbamyl group rather than bind to a small one. The hydrophobicity of carbamates 24-31 does not play a major role in both enzyme inhibitions.
制备了烷基 - N - 苯基氨基甲酸酯(2 - 8)(见图1)、烷基 - N - 苯基硫代氨基甲酸酯(9 - 15)、2,2'-联苯 - 2 - 醇 - 2'-N - 取代氨基甲酸酯(16 - 23)以及2,2'-联苯 - 2 - N - 十八烷基氨基甲酸酯 - 2'-N - 取代氨基甲酸酯(24 - 31),并评估了它们对猪胰胆固醇酯酶和假单胞菌属脂肪酶的抑制作用。所有抑制剂均被表征为这两种酶的瞬时或假底物抑制剂。在三氟苯乙酮存在下,氨基甲酸酯2 - 8和硫代氨基甲酸酯9 - 15对这两种酶均无保护作用,且会进一步使其失活。因此,氨基甲酸酯2 - 8和硫代氨基甲酸酯9 - 15是活性位点结合抑制剂的例外情况,可能是这两种酶的第二个烷基链结合位点导向抑制剂。氨基甲酸酯2 - 8和硫代氨基甲酸酯9 - 15的抑制数据与空间常数E(s)和疏水性常数π相关;然而,抑制数据与塔夫脱取代常数σ无关。氨基甲酸酯2 - 8和硫代氨基甲酸酯9 - 15对这两种酶的抑制数据比较表明,硫代氨基甲酸酯9 - 15比氨基甲酸酯2 - 8是更有效的抑制剂。氨基甲酸酯2 - 8或硫代氨基甲酸酯9 - 15对胆固醇酯酶和假单胞菌属脂肪酶的抑制数据比较表明,胆固醇酯酶比假单胞菌属脂肪酶对E(s)和π值更敏感。氨基甲酸酯2 - 8和硫代氨基甲酸酯9 - 15对假单胞菌属脂肪酶抑制数据的对数与E(s)和π的负斜率值表明,与胆固醇酯酶相比,假单胞菌属脂肪酶的第二个烷基链结合位点巨大且亲水,更倾向于与体积大、亲水性的抑制剂相互作用,而不是与体积小、疏水性的抑制剂相互作用。相反,胆固醇酯酶的第二个烷基链结合位点更倾向于结合体积小、疏水性的抑制剂。在三氟苯乙酮存在下,氨基甲酸酯16 - 23对这两种酶均有保护作用,使其免受抑制。因此,氨基甲酸酯16 - 23被表征为这两种酶的烷基链结合位点、酯解位点氧阴离子活性位点导向的假底物抑制剂。氨基甲酸酯16 - 22的两种酶抑制数据仅与σ相关性良好。这些相关性的负ρ值表明,这两种酶的丝氨酸残基与氨基甲酸酯16 - 22形成的四面体物种比抑制剂和酶带有更多正电荷,并且随后形成的氨甲酰酶比四面体物种带有更多正电荷。氨基甲酸酯24 - 31也是活性位点结合抑制剂的例外情况,可能是这两种酶的第二个烷基链结合位点导向抑制剂。然而,氨基甲酸酯24 - 31的酶抑制常数与σ、E(s)和π值相关。这些相关性的负ρ值表明,这两种酶与氨基甲酸酯24 - 31形成的四面体物种比抑制剂和酶带有更多正电荷,并且随后形成的氨甲酰酶比那些四面体物种带有更多正电荷。因此,氨基甲酸酯24 - 31可能同时结合活性位点和第二个烷基链结合位点,并伴随着活性位点的排空。氨基甲酸酯24 - 31对胆固醇酯酶和假单胞菌属脂肪酶的ρ值比较表明,胆固醇酯酶比假单胞菌属脂肪酶对σ值更敏感得多。氨基甲酸酯24 - 31对胆固醇酯酶抑制的负敏感性值δ表明,该酶更倾向于结合体积大的氨甲酰基团而不是体积小的氨甲酰基团。氨基甲酸酯24 - 31的疏水性在两种酶的抑制中不起主要作用。